Tag: drug development

STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill

WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a...

STAT+: Ultragenyx cuts staff after another study fails 

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in...

STAT+: Who will get the first psychedelic approved?

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by...

STAT+: Psilocybin’s lasting benefits prove elusive in mice

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in...

STAT+: HHS green lights six peptides, despite concerns from FDA scientists

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in...

STAT+: Biopharma industry at odds over impact of Treasury’s new China rule

WASHINGTON — Ever since the Treasury Department proposed to limit U.S. investment in the Chinese biotech industry last week,...

Anthropic Says It Will Revolutionize Biology—Some Day

AI giant Anthropic and CEO Dario Amodei have repeatedly claimed that the company’s models will revolutionize biology and drug...

STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

WASHINGTON – The Food and Drug Administration published draft guidance on Tuesday that would streamline approvals of some individualized...

STAT+: RFK Jr. goes for broke in Iowa

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and...